Carsten Rose

5.2k total citations
69 papers, 2.4k citations indexed

About

Carsten Rose is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Carsten Rose has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 31 papers in Cancer Research and 27 papers in Genetics. Recurrent topics in Carsten Rose's work include Breast Cancer Treatment Studies (25 papers), Estrogen and related hormone effects (24 papers) and Cancer Risks and Factors (13 papers). Carsten Rose is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Estrogen and related hormone effects (24 papers) and Cancer Risks and Factors (13 papers). Carsten Rose collaborates with scholars based in Sweden, Denmark and United Kingdom. Carsten Rose's co-authors include Christian Ingvar, Helena Jernström, Andrea Markkula, Maria Simonsson, Per Pfeiffer, Signe Borgquist, Kjeld Andersen, Karin Jirström, Carsten Peterson and Mårten Fernö and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Carsten Rose

67 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carsten Rose Sweden 28 1.2k 998 602 522 514 69 2.4k
Moïse Namer France 25 1.8k 1.5× 1.1k 1.1× 437 0.7× 496 1.0× 419 0.8× 62 2.8k
Aliana Guerrieri‐Gonzaga Italy 30 1.2k 1.0× 858 0.9× 970 1.6× 816 1.6× 292 0.6× 106 2.6k
Harriet Johansson Italy 29 1.0k 0.9× 710 0.7× 846 1.4× 845 1.6× 273 0.5× 83 2.5k
Mingxin Che United States 25 582 0.5× 440 0.4× 703 1.2× 239 0.5× 457 0.9× 36 1.9k
Tristan M. Sissung United States 30 1.4k 1.2× 506 0.5× 1.2k 2.1× 384 0.7× 635 1.2× 94 2.9k
Tetsuo Kuroishi Japan 27 1.4k 1.2× 462 0.5× 666 1.1× 465 0.9× 697 1.4× 74 3.0k
Signe Borgquist Sweden 34 1.4k 1.2× 1.9k 1.9× 1.1k 1.8× 610 1.2× 764 1.5× 167 3.6k
Ignasi Tusquets Spain 23 970 0.8× 627 0.6× 608 1.0× 448 0.9× 219 0.4× 73 1.9k
Stener Kvinnsland Norway 30 1.2k 1.0× 635 0.6× 734 1.2× 1.3k 2.5× 234 0.5× 106 3.0k
G. Di Fronzo Italy 30 1.7k 1.5× 1.4k 1.4× 1.1k 1.8× 780 1.5× 376 0.7× 93 3.3k

Countries citing papers authored by Carsten Rose

Since Specialization
Citations

This map shows the geographic impact of Carsten Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Rose more than expected).

Fields of papers citing papers by Carsten Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Rose. The network helps show where Carsten Rose may publish in the future.

Co-authorship network of co-authors of Carsten Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Rose. A scholar is included among the top collaborators of Carsten Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Rose. Carsten Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simonsson, Maria, et al.. (2018). Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis. Cancer Causes & Control. 29(7). 643–656. 16 indexed citations
2.
Dunlop, Alex, H. Chantler, N. Twyman, et al.. (2018). A Dosimetric Comparison of Breast Radiotherapy Techniques to Treat Locoregional Lymph Nodes Including the Internal Mammary Chain. Clinical Oncology. 30(6). 346–353. 74 indexed citations
3.
Rosendahl, Ann H., Maria Simonsson, Andrea Markkula, et al.. (2017). Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer. Frontiers in Endocrinology. 8. 332–332. 4 indexed citations
4.
Simonsson, Maria, Srinivas Veerla, Andrea Markkula, et al.. (2016). CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients. BMC Cancer. 16(1). 256–256. 12 indexed citations
5.
Simonsson, Maria, et al.. (2016). Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort. British Journal of Cancer. 115(3). 382–390. 32 indexed citations
6.
Rosendahl, Ann H., Claire M. Perks, Li Zeng, et al.. (2015). Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer. Clinical Cancer Research. 21(8). 1877–1887. 129 indexed citations
7.
Simonsson, Maria, et al.. (2015). History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response. Breast Cancer Research and Treatment. 149(2). 505–515. 9 indexed citations
8.
Markkula, Andrea, Maria Simonsson, Christian Ingvar, Carsten Rose, & Helena Jernström. (2014). IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort. BMC Cancer. 14(1). 759–759. 19 indexed citations
9.
Simonsson, Maria, et al.. (2013). Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status. Cancer Causes & Control. 24(5). 929–940. 31 indexed citations
10.
11.
Borgquist, Signe, et al.. (2012). Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms. Breast Cancer Research and Treatment. 137(3). 849–862. 10 indexed citations
12.
Markkula, Andrea, et al.. (2012). Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort. Cancer Causes & Control. 23(8). 1307–1316. 30 indexed citations
13.
Lundin, Kristina, et al.. (2011). Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients. British Journal of Cancer. 105(11). 1676–1683. 30 indexed citations
14.
Ingvar, Christian, et al.. (2010). Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden. Acta Oncologica. 50(1). 134–143. 19 indexed citations
15.
Rose, Carsten, A Płużańska, Nancy E. Davidson, et al.. (2003). An open randomised trial of second-line endocrine therapy in advanced breast cancer. European Journal of Cancer. 39(16). 2318–2327. 145 indexed citations
16.
Johansen, Jørgen, Jens Overgaard, Carsten Rose, et al.. (2002). Cosmetic Outcome and Breast Morbidity in Breast-Conserving Treatment. Acta Oncologica. 41(4). 369–380. 67 indexed citations
17.
Leleu, Xavier, et al.. (1998). [Primary biliary cirrhosis revealed by autoimmune thrombopenic purpura].. PubMed. 27(37). 1897–8.
18.
19.
Cold, Søren, Niels Viggo Jensen, H Brincker, & Carsten Rose. (1993). The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s. European Journal of Cancer. 29(8). 1146–1152. 36 indexed citations
20.
Jakobsen, Preben, Lars Bastholt, M. Dalmark, et al.. (1991). A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. Cancer Chemotherapy and Pharmacology. 28(6). 465–469. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moïse Namer Breakdown of academic impact, for papers by Aliana Guerrieri‐Gonzaga Breakdown of academic impact, for papers by Harriet Johansson Breakdown of academic impact, for papers by Mingxin Che Breakdown of academic impact, for papers by Tristan M. Sissung Breakdown of academic impact, for papers by Tetsuo Kuroishi Breakdown of academic impact, for papers by Signe Borgquist Breakdown of academic impact, for papers by Ignasi Tusquets Breakdown of academic impact, for papers by Stener Kvinnsland Breakdown of academic impact, for papers by G. Di Fronzo
Rankless by CCL
2026